Impavido (miltefosine capsules - Profounda) — Cigna
Leishmaniasis (cutaneous, mucosal, or visceral)
Initial criteria
- Patient has ONE of the following: cutaneous leishmaniasis OR mucosal leishmaniasis OR visceral leishmaniasis
- Medication is prescribed by or in consultation with an infectious diseases specialist
Approval duration
1 month